MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MP-23-0046188
Biogen Therapeutics Private Limited
Biogen Therapeutics Private Limited - chemicals in Indore, Madhya Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹2.56 Cr
▲ 29% YoY
Net profit · FY 2025
₹2.91 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹10.02 Lakh
EBITDA margin 3.9%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹70 Lakh
Satisfied ₹70 Lakh
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
About Biogen Therapeutics Private Limited
Data last updated:
Biogen Therapeutics Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 25 January 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24299MP2022PTC059277.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Arpit Bafna and Karishma Bafna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. G – 58 Dawa Bazar 13 – 14 Rnt Marg, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.56 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.91 Lakh (net margin 1.1%) and EBITDA of ₹10.02 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 145% over three years.
As per MCA filings, the company has open charges of ₹70 Lakh and satisfied charges of ₹70 Lakh on record.
Biogen Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0046188).
Company details
CIN U24299MP2022PTC059277
Registration Number 059277
Incorporation Date 25 January 2022
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0046188
Key People
Arpit Bafna Director Karishma Bafna Director Recognitions & Rankings of Biogen Therapeutics
Contact details
Biogen Therapeutics Private Limited's registered office is in Indore, Madhya Pradesh.
- Registered AddressShop No. G – 58 Dawa Bazar 13 – 14 Rnt Marg, Indore, Madhya Pradesh, India – 452001
- IndustryChemicals, Other Chemical Product, Manufacturing, Fine Chemicals And Other Chemical Products
Comprehensive company report
Biogen Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biogen Therapeutics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biogen Therapeutics Private Limited, buy the company report.
Financials of Biogen Therapeutics Private Limited
FY 2025 filings availableBiogen Therapeutics Private Limited reported revenue of ₹2.56 Cr (up 29% YoY) for FY 2025.
Revenue · FY 2025
₹2.56 Cr ▲ 29%
Net profit · FY 2025
₹2.91 Lakh margin 1.1%
EBITDA · FY 2025
₹10.02 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 145%
EBITDA CAGR growth
1 year
▲ 43%
3 years · compounded
▲ 383%
Revenue has grown at a compounded annual rate (CAGR) of 145% over three years, including 29% growth in the latest year. EBITDA rose 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹10.02 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.91 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 3.9% | |||
| Net Profit Margin | 1.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Biogen Therapeutics Private Limited, buy the company report.
Board of directors of Biogen Therapeutics Private Limited
Biogen Therapeutics has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arpit Bafna Also directs: Acne Care Clinics Private Limited | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
| Karishma Bafna Also directs: Rushr Lifescience Private Limited | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
Biogen Therapeutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shreejee Trade Ventures Private Limited | ₹2.56 Cr (FY 2025) | -6.0% | Meerut, Uttar Pradesh, India | |||
| G2 Farmer Producer Company Limited | ₹2.56 Cr (FY 2025) | 40.0% | Pune, Maharashtra, India | |||
| Ekaksh Commerce Private Limited | ₹2.56 Cr (FY 2025) | 160.0% | Kolkata, West Bengal, India | |||
| Dasenlin India Private Limited | ₹2.56 Cr (FY 2023) | Surat, Gujarat, India | ||||
| Tree House Creations Private Limited | ₹2.56 Cr (FY 2024) | -51.0% | Greater Noida, Uttar Pradesh, India | |||
| Biogen Therapeutics Private Limitedthis company | ₹2.56 Cr (FY 2025) | ₹2.91 Lakh | 1.1% | 29.0% | Indore, Madhya Pradesh, India | |
| Deep Beverages Private Limited | ₹2.56 Cr (FY 2024) | 4.0% | Kanpur, Uttar Pradesh, India | |||
| Karishma Vintrade Private Limited | ₹2.56 Cr (FY 2025) | -72.0% | Kolkata, West Bengal, India | |||
| Jme Steel Private Limited | ₹2.56 Cr (FY 2025) | -12.0% | Kolkata, West Bengal, India | |||
| Reshmi Merchandise Private Limited | ₹2.56 Cr (FY 2025) | 365.0% | Kolkata, West Bengal, India | |||
| Prodev Pharma (OPC) Private Limited | ₹2.56 Cr (FY 2025) | -45.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Biogen Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹70 Lakh
Satisfied charges
₹70 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2023 | 100841235 | Others | ₹50 Lakh | Satisfied | |
| 04 Mar 2023 | 100691376 | Others | ₹20 Lakh | Satisfied |
To see the full charge records of Biogen Therapeutics Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Biogen Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biogen Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biogen Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biogen Therapeutics Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Arpit Bafna was appointed as Director on 25 Jan 2022.
Charges
A charge registered on 12 Dec 2023 via Charge ID 100841235 with Others was fully satisfied on 12 Nov 2025.
Charges
A charge registered on 04 Mar 2023 via Charge ID 100691376 with Others was fully satisfied on 12 Nov 2025.
AGM
Biogen Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biogen Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 100841235 was registered on 12 Dec 2023.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100691376 was registered on 04 Mar 2023.
Appointed
Arpit Bafna was appointed as Director.
Appointed
Karishma Bafna was appointed as Director.
Incorporation
25 Jan 2022
Biogen Therapeutics Private Limited was registered on 25 Jan 2022 with Roc Gwalior & aged 4 years 9 months as per MCA records.
Frequently asked questions
Biogen Therapeutics is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 25 January 2022 (4+ years old) and is registered under CIN U24299MP2022PTC059277.
Biogen Therapeutics has 2 current directors:
- Arpit Bafna - Director
- Karishma Bafna - Director
The latest financial statements of Biogen Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Biogen Therapeutics is U24299MP2022PTC059277. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biogen Therapeutics was incorporated on 25 January 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Biogen Therapeutics by revenue are Shreejee Trade Ventures Private Limited, G2 Farmer Producer Company Limited, Ekaksh Commerce Private Limited, Dasenlin India Private Limited, Tree House Creations Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Arpit Bafna was appointed as Director on 25 Jan 2022. Karishma Bafna was appointed as Director on 25 Jan 2022.
Yes, Biogen Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0046188).
The registered office of Biogen Therapeutics is at Shop No. G – 58 Dawa Bazar 13 – 14 Rnt Marg, Indore, Madhya Pradesh, India – 452001.
Biogen Therapeutics operates in the chemicals industry, in the other chemical product segment.
Biogen Therapeutics has open charges of ₹70 Lakh and satisfied charges of ₹70 Lakh as per latest MCA filings.